Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. 1983

L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015251 Epirubicin An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA. 4'-Epiadriamycin,4'-Epidoxorubicin,4'-Epi-Adriamycin,4'-Epi-DXR,4'-Epi-Doxorubicin,EPI-cell,Ellence,Epilem,Epirubicin Hydrochloride,Farmorubicin,Farmorubicina,Farmorubicine,IMI-28,NSC-256942,Pharmorubicin,4' Epi Adriamycin,4' Epi DXR,4' Epi Doxorubicin,4' Epiadriamycin,4' Epidoxorubicin,EPI cell,EPIcell,Hydrochloride, Epirubicin,IMI 28,IMI28,NSC 256942,NSC256942

Related Publications

L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
November 1990, Investigational new drugs,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
March 1984, Cancer treatment reports,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
October 1985, American journal of clinical oncology,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
April 1984, Cancer treatment reports,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
January 1990, Medical oncology and tumor pharmacotherapy,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
September 1987, Cancer treatment reports,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
November 1985, Cancer treatment reports,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
December 1984, Cancer treatment reports,
L A Kalman, and M G Kris, and R J Gralla, and D P Kelsen, and E S Casper, and R T Heelan, and R E Wittes
January 1984, Investigational new drugs,
Copied contents to your clipboard!